EN DE

BioMar Group (BIOMAR) Fair Value & Analysis

Consumer Defensive · DK · Market cap 11.2B DKK

BG BioMar Group BIOMAR · CO
Pricekr 110.00
Fair Valuekr 120.82
Upside+9.8%
Quality62/100
Weak Growth
Thin margins · 4.4% net margin
Low debt · generates free cash flow
Trails peers (5/13)
Narrow moat 25/100
Watch BioMar Group for free, get notified when fair value or trend changes. Watch for free
Evidence: Medium Range kr 90.62 – kr 162.59 Share as image

Fair value as of: Jul 31, 2026

From 18 valuation models · updated today

Share price +4.8% over the past month.

Price vs Fair Value (2 months)

kr 119.10 kr 105.00 Fair Value kr 120.82 May 2026 Jul 2026

2‑month range kr 105.00 – kr 119.10 · fair‑value band kr 90.62 – kr 162.59 · the kr 110.00 price screens below the kr 120.82 fair value. As of Jul 31, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

BioMar Group (BIOMAR) currently trades at kr 110.00, while our model-based Fair Value estimate is kr 120.82, implying the stock looks roughly 9.8% fairly valued today. We read business quality at 62/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, BioMar Group generated revenue of 16.3B DKK at a net margin of 4.4%. Revenue declined 5.8% year over year. Net debt stands at 2.8B DKK. The stock trades on a trailing P/E of 15.8. Fundamentals as of Jul 31, 2026

Our scenario range runs from kr 90.62 (bear case) to kr 162.59 (bull case); at kr 110.00, the current price sits within that range. The share trades about 8% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 75% fair-value upside, at 10%, BIOMAR screens richer than that median.

Key figures & financial health

Revenue (TTM) 16.3B DKK
Revenue growth (YoY) -5.8%
Net margin 4.4%
Free cash flow 1.3B DKK FY2025
P/E ratio 15.8
Operating margin 3.4%
More key figures
EPS (TTM) kr 7.06
EPS growth (YoY) -7.1%
Net debt 2.8B DKK FY2025

Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100
Profitability 63
Quality Growth 47
Cashflow 65
Fin. Strength 59
Investment 100
52W Momentum 38
Net Issuance 80

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

BioMar Group A/S provides feeding solutions in the aquaculture industry in Denmark. It operates through four segments: Salmon, Shrimp, Selected Species, and Tech Solutions. The company develops, produces, and delivers feeding solutions for species, such as salmon, shrimp, sea bass, sea bream, trout, turbot, and sturgeon to farmers.

Full company description

BioMar Group A/S provides feeding solutions in the aquaculture industry in Denmark. It operates through four segments: Salmon, Shrimp, Selected Species, and Tech Solutions. The company develops, produces, and delivers feeding solutions for species, such as salmon, shrimp, sea bass, sea bream, trout, turbot, and sturgeon to farmers. It also offers aquaculture feed solutions for Atlantic and Pacific salmon, warm-water shrimp, and other special species. In addition, the company provides AI-based technology solutions for aquacultural feeding and farming. BioMar Group A/S was formerly known as Dansk Ørredfoder A/S and changed its name to BioMar Group A/S in 1994. The company was incorporated in 1962 and is based in Aarhus, Denmark. BioMar Group A/S operates as a subsidiary of Aktieselskabet Schouw & Co.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2023 – FY2025 · reported fiscal years

BioMar Group reported revenue of kr 16.5B in FY2025 versus kr 17.9B in FY2023, a compound −3.8%/yr. Reported net income was kr 714M in FY2025, compounding +24.5%/yr from FY2023.

Revenue −3.8%/yr
FY23 kr 17.9B
FY24 kr 16.6B
FY25 kr 16.5B
Net income +24.5%/yr
FY23 kr 461M
FY24 kr 675M
FY25 kr 714M

Is BIOMAR fairly valued? → Check now

Share or link this analysis
📋 Free embed code + live data for your site

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "BioMar Group Fair Value". https://www.fairvalue-calculator.com/stock/BIOMAR

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 46 / 29
FUTURE 0 / 24
PAST 0 / 16
HEALTH 99 / 94
DIVIDEND 0 / 42

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).

Stock Price Fair Value vs Fair Value
Archer-Daniels-Midland Company ADM $76.29 $46.97 -38%
Muyuan Foods Group 002714 ¥33.95 ¥59.53 +75%
Wens Foodstuff Group 300498 ¥12.83 ¥7.44 -42%
Mowi ASA MOWI kr 194.40 kr 23.52 -88%
SalMar ASA SALM kr 574.50 kr 57.93 -90%
PT Charoen Pokphand Indonesia Tbk, CPIN 3,170 IDR 7,228 IDR +128%
Charoen Pokphand Foods Public Company CPF 19.20 THB 57.92 THB +202%
PT Triputra Agro Persada Tbk TAPG 1,350 IDR 3,337 IDR +147%
PT FAP Agri Tbk FAPA 7,300 IDR 7,528 IDR +3%
Thaifoods Group TFGR 8.75 THB 23.54 THB +169%

Compare BioMar Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is BioMar Group (BIOMAR) overvalued or undervalued?
As of Jul 31, 2026, our model estimates a fair value of kr 120.82 versus a price of kr 110.00, about +10% (fairly valued).
What is the fair value of BIOMAR?
Our model-based fair value for BioMar Group is kr 120.82 (as of Jul 31, 2026), built from audited fundamentals. The current price is kr 110.00.
What is the quality score of BIOMAR?
BioMar Group has a Quality Score of 62/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of BioMar Group (BIOMAR)?
BioMar Group reported trailing-twelve-month revenue of about 16.3B DKK (latest available figure, as of Jul 31, 2026).
What is the net profit margin of BIOMAR?
The net profit margin of BioMar Group is about 4.4%, meaning it keeps roughly 4.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track BioMar Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.